| scholarly article | Q13442814 |
| P356 | DOI | 10.1024/0301-1526/A000913 |
| P698 | PubMed publication ID | 33138736 |
| P50 | author | Nicholas Bradley | Q90946604 |
| P2093 | author name string | Faisel Khan | |
| Campbell Roxburgh | |||
| Graeme Guthrie | |||
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 |
| Tocilizumab | Q24655317 | ||
| Integrating Interleukin-6 into depression diagnosis and treatment | Q28070891 | ||
| Epidemiology of aortic aneurysm repair in the United States from 2000 to 2010 | Q28307908 | ||
| Influence of mesh materials on the expression of mediators involved in wound healing | Q28583767 | ||
| The Systemic Inflammatory Response Syndrome (SIRS) in acutely hospitalised medical patients: a cohort study. | Q33589699 | ||
| Post-implantation syndrome following endovascular abdominal aortic aneurysm repair: preliminary data | Q33797515 | ||
| Antipyretic therapy: physiologic rationale, diagnostic implications, and clinical consequences | Q33850660 | ||
| Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future | Q34026963 | ||
| Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery | Q34198436 | ||
| IL-6 in inflammation, immunity, and disease | Q34248105 | ||
| Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial | Q34270319 | ||
| An 8-year experience with type II endoleaks: natural history suggests selective intervention is a safe approach | Q34563052 | ||
| Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiova | Q35016884 | ||
| Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies | Q35863952 | ||
| Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway | Q35995696 | ||
| Thoracic and abdominal aortic aneurysms | Q36041517 | ||
| Risk factors and consequences of persistent type II endoleaks | Q36731346 | ||
| Fatigue and interleukin-6 - a multi-faceted relationship | Q36842411 | ||
| Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis | Q36986500 | ||
| Platelet activation and platelet-leukocyte aggregation elicited in experimental colitis are mediated by interleukin-6. | Q37625690 | ||
| Procalcitonin for guidance of antibiotic therapy | Q37747406 | ||
| Glucocorticoids and cardiovascular risk factors | Q37874810 | ||
| Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events. | Q38247488 | ||
| Preoperative methylprednisolone enhances recovery after endovascular aortic repair: a randomized, double-blind, placebo-controlled clinical trial | Q38425487 | ||
| Results from the Multicenter Study on Aortoenteric Fistulization After Stent Grafting of the Abdominal Aorta (MAEFISTO). | Q39690689 | ||
| The Impact of Stent Graft Material on the Inflammatory Response After EVAR. | Q40146786 | ||
| Prospective evaluation of post-implantation inflammatory response after EVAR for AAA: influence on patients' 30 day outcome | Q40174225 | ||
| Volume of new-onset thrombus is associated with the development of postimplantation syndrome after endovascular aneurysm repair. | Q40202823 | ||
| Stent graft composition plays a material role in the postimplantation syndrome | Q40270511 | ||
| Perigraft air, fever, and leukocytosis after endovascular repair of abdominal aortic aneurysms | Q40631327 | ||
| Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-alpha | Q40805055 | ||
| Prospective evaluation of postimplantation syndrome evolution on patient outcomes after endovascular aneurysm repair for abdominal aortic aneurysm | Q40880562 | ||
| Preliminary Results from a National Enquiry of Infection in Abdominal Aortic Endovascular Repair (Registry of Infection in EVAR--R.I.EVAR). | Q40980370 | ||
| Interleukin 6 Inhibition and Coronary Artery Disease in a High-Risk Population: A Prospective Community-Based Clinical Study | Q41103987 | ||
| Elevated serum interleukin-6 is predictive of coronary artery disease in intermediate risk overweight patients referred for coronary angiography | Q41624829 | ||
| Management of Endoleaks following Endovascular Aneurysm Repair | Q41790972 | ||
| The role of procalcitonin in postimplantation syndrome after EVAR: a pilot study | Q42232381 | ||
| Clinical significance of type II endoleak after endovascular repair of abdominal aortic aneurysm | Q42676714 | ||
| Glucocorticoid treatment and cardiovascular disease | Q43013452 | ||
| The impact of endograft type on inflammatory response after endovascular treatment of abdominal aortic aneurysm. | Q45719060 | ||
| Evaluation of serum levels of interleukin-6 and interleukin-10 in patients undergoing laparoscopic versus conventional cholecystectomy | Q48172093 | ||
| Postimplantation syndrome after endovascular aortic repair using the Anaconda™ endograft. | Q51153619 | ||
| Transfemoral Intraluminal Graft Implantation for Abdominal Aortic Aneurysms | Q51703194 | ||
| Volume of mural thrombus plays a role in the elevation of inflammatory markers after endovascular aortic repair. | Q55220562 | ||
| Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation | Q56835689 | ||
| Polyester Grafts Are a Risk Factor for Postimplantation Syndrome after Abdominal Endovascular Aneurysm Repair: Retrospective Analysis for Polyester Graft, Excluder®, and Endologix Powerlink®/AFX® | Q60934448 | ||
| Elevation of circulating interleukin 6 after surgery: factors influencing the serum level | Q72062635 | ||
| Tumor necrosis factor-alpha and interleukin-6 release from white blood cells induced by different graft materials in vitro are affected by pentoxifylline and iloprost | Q73593741 | ||
| Controlling the expansion of abdominal aortic aneurysms | Q73775269 | ||
| Adverse reactions during endovascular treatment of aortic aneurysms may be triggered by interleukin 6 release from the thrombotic content | Q77456636 | ||
| Current Evidence on Management of Aortic Stent-graft Infection: A Systematic Review and Meta-Analysis | Q88717051 | ||
| Risk factors and treatment outcomes for stent graft infection after endovascular aortic aneurysm repair | Q90743845 | ||
| Editor's Choice - Systematic Review and Meta-Analysis of the Outcome of Treatment for Type II Endoleak Following Endovascular Aneurysm Repair | Q90925599 | ||
| Open and Endovascular Management of Aortic Aneurysms | Q91577804 | ||
| Incidence, natural course, and outcome of type II endoleaks in infrarenal endovascular aneurysm repair based on the ENGAGE registry data | Q92829345 | ||
| New predictors of aneurysm sac behavior after endovascular aortic aneurysm repair | Q93093289 | ||
| P304 | page(s) | 1-12 | |
| P577 | publication date | 2020-11-03 | |
| P1433 | published in | Vasa | Q15767573 |
| P1476 | title | Postimplantation syndrome in endovascular aortic aneurysm repair - a systematic review |
Search more.